-
Symbol
-
LYEL on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001
-
Latest Disclosed Shares Owned
-
1,040,964 shares
-
Security Ownership %
-
5.6%
Gates Frontier, LLC ownership in Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL)
01 Aug 2025 - Gates Frontier, LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,040,964 shares of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).
This represents 5.6% ownership of the company.
This is the first filing by Gates Frontier, LLC disclosing ownership of Lyell Immunopharma, Inc. Common Stock, par value $0.0001 (LYEL).